A 73-year-old man developed graft-versus-host disease (GVHD) after blood transfusion; he developed hepatitis, fever, rash, and pancytopenia. Although similar cases have been previously reported, the spectra of their liver injury was not clarified. The clinical and pathological findings of this case and a review of earlier reports suggest a possible predominance of hepatocellular injury in cases of GVHD after blood transfusion, which is in contrast to the prevalence of cholestatic liver disease in GVHD following bone marrow transplantation.
cases that occurred after bone marrowtransplantation, and only a few reports focus on hepatic injury in GVHDthat developed after blood transfusion.
In Japan, more than 50 cases of GVHD-like reaction have been reported after blood transfusion in patients who were not severely immunocompromised (1-4), but there is none in the English literature (5-1 1). We present a patient with GVHD who showed hepatocellular injury, and a review of other earlier reports, to clarify the clinical and pathological spectra of liver injury in GVHDafter blood transfusion.
CASE REPORT
A 73-year-old man underwent surgery for squamous cell carcinoma of the neck; he received a 5,400 ml blood transfusion of which 2,000 ml was fresh blood. His postoperative course was uneventful until the 10th postoperative day, when he developed high fever followed by a red, maculopapular skin rash on the trunk, soles, and palms. On the 15th postoperative day his liver tests showed an aspartate aminotransferase (AST) of 1,009 IU, an alanine aminotransferase (ALT) of 1 ,057 IU, an alkaline phosphatase of 326 IU/1, and a total bilirubin of 1.1 mg/ml. On examination he was drowsy but responsive to verbal stimuli, and no flapping tremor was observed. The liver was palpable 2 cmbelow the right costal margin. Ascites and pretibial edema were not present. Ultrasound showed slight hepatomegaly without dilatation of the biliary tract or hepatic masses. On the 17th day profound pancytopenia developed, complicated by sepsis and pneumonia, leading to death on the 20th postoperative day. The test for hepatitis B surface antigen was negative, as was IgM antibody for hepatitis A (HA) and cytomegalovirus (CMV). His clinical course is summarized in Fig. 1 . A cardinal pathological change in the liver at autopsy was focal necrosis of hepatocytes accompanied by sparse lymphocyte infiltration. No central venulitis was discerned. The portal tract was edematous and enlarged without prominent lymphocytic infiltration. The bile duct epithelium showed no necrosis or degeneration in 20 portal tracts examined. In Japan, a similar illness has long been classified as postoperative erythema (POE) (13), but its etiology was unclarified until Sakakibara and Juji (4) observed a lymphocyte with the donor's HLA typing surviving in the recipient's peripheral blood, suggesting a form of GVHDassociated with blood transfusion. Sakakibara and Juji attributed the high incidence of POEto the commonpractice of using fresh blood in Japan.
The present case showed hepatocellular injury both clinically and pathologically, in contrast to the typical prevalence of cholestatic injury in GVHD associated with bone marrow transplantation. Thus, we reviewed earlier reports on GVHD associated with blood transfusion in Japan. As shown in Table  2 , most such patients showed moderate to marked elevation of serum transaminase, with a normal to mild elevation of alkaline phosphatase and bilirubin, suggesting hepatocellular injury as predominant (12) (13) (14) (15) (16) (17) (18) (19) . In most cases ALTwas reported to be higher than AST, and the onset of marked elevation of transaminase was 2 to 3 days after the appearance of fever and rash. To our knowledge there was only two reports describing the liver histology: one reporting Kupffer cell hyperplasia (19) and another massive necrosis of hepatocytes (5).
Although the typical liver histology finding of GVHD after bone marrow transplantation is bile duct injury, Beschorner et al. reported predominant hepatocellular necrosis in the hyperacute form (0-14 days) of acute GVHD (2). There are many possible explanations for the differences between liver injury in GVHDafter blood transfusion and that after bone marrow transplantation.
The immunological mechanisms Although numerous clinical and pathological observations are necessary to clarify the characteristics of the liver injury in GVHDafter blood transfusion, it can be suggested based on earlier reports, the present findings, and the similarity to the hyperacute form of GVHD seen after bone marrowtransplantation, that most cases might predominantly be hepatocellular injury. 
